Literature DB >> 24919499

Liver in the analysis of body composition by dual-energy X-ray absorptiometry.

A Bazzocchi1, D Diano, U Albisinni, G Marchesini, G Battista, G Guglielmi.   

Abstract

OBJECTIVE: To investigate the predictive value for hepatic steatosis of a new software for the quantification of visceral fat by dual-energy X-ray absorptiometry (DXA) and to design new regions of interest (ROIs).
METHODS: Adult volunteers were prospectively screened for hepatic steatosis by ultrasonography to obtain a well-balanced population according to the presence/absence of the disease. 90 adult patients without steatosis and 90 with steatosis (mild, 53.3%; moderate, 37.7%; and severe, 10.0%) were recruited. On the same day, all subjects were submitted to blood testing and to anthropometric and whole-body DXA for body composition evaluation. A new software for android visceral fat assessment was employed, and six new "liver-suited" ROIs as well as two modified android ROIs were designed. Their association with steatosis grade was tested by correlation analysis.
RESULTS: Fat mass (FM) of the new ROIs showed the highest correlation coefficients with steatosis grade (ρ = 0.610-0.619; p < 0.001), which was also confirmed by multivariate analysis. On the whole population, the new ROIs maintained the highest predictive role for liver steatosis, with areas under the receiver operating characteristic curve up to 0.820 ± 0.032. Inter- and intra-operator agreement for the new ROIs was excellent (k = 0.915-1.000 and k = 0.927-1.000).
CONCLUSION: New ROIs could be designed, standardized and implemented in DXA whole-body scan to provide more specific and predictive values of hepatic lipid content. ADVANCES IN KNOWLEDGE: This is the first study to investigate the predictive value for hepatic steatosis of visceral and regional FM assessed on the hepatic site by DXA in comparison with ultrasonography, anthropometry and surrogate markers derived by previously validated algorithms (fatty liver index).

Entities:  

Mesh:

Year:  2014        PMID: 24919499      PMCID: PMC4453154          DOI: 10.1259/bjr.20140232

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  33 in total

1.  Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT.

Authors:  Cody J Boyce; Perry J Pickhardt; David H Kim; Andrew J Taylor; Thomas C Winter; Richard J Bruce; Mary J Lindstrom; J Louis Hinshaw
Journal:  AJR Am J Roentgenol       Date:  2010-03       Impact factor: 3.959

Review 2.  Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.

Authors:  Jean-Pierre Després; Isabelle Lemieux; Jean Bergeron; Philippe Pibarot; Patrick Mathieu; Eric Larose; Josep Rodés-Cabau; Olivier F Bertrand; Paul Poirier
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03-20       Impact factor: 8.311

Review 3.  Subcutaneous and visceral adipose tissue: structural and functional differences.

Authors:  M Mohsen Ibrahim
Journal:  Obes Rev       Date:  2009-07-28       Impact factor: 9.213

4.  Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

Authors:  Caroline S Fox; Joseph M Massaro; Udo Hoffmann; Karla M Pou; Pal Maurovich-Horvat; Chun-Yu Liu; Ramachandran S Vasan; Joanne M Murabito; James B Meigs; L Adrienne Cupples; Ralph B D'Agostino; Christopher J O'Donnell
Journal:  Circulation       Date:  2007-06-18       Impact factor: 29.690

5.  Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk.

Authors:  Marco C Amato; Carla Giordano; Massimo Galia; Angela Criscimanna; Salvatore Vitabile; Massimo Midiri; Aldo Galluzzo
Journal:  Diabetes Care       Date:  2010-01-12       Impact factor: 17.152

6.  Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study.

Authors:  Beverley Balkau; Celine Lange; Sylviane Vol; Frederic Fumeron; Fabrice Bonnet
Journal:  BMC Gastroenterol       Date:  2010-06-07       Impact factor: 3.067

7.  Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy.

Authors:  Boris Guiu; Jean-Michel Petit; Romaric Loffroy; Douraied Ben Salem; Serge Aho; David Masson; Patrick Hillon; Denis Krause; Jean-Pierre Cercueil
Journal:  Radiology       Date:  2009-01       Impact factor: 11.105

Review 8.  Assessment methods in human body composition.

Authors:  Seon Yeong Lee; Dympna Gallagher
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-09       Impact factor: 4.294

9.  Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

Authors:  Masahide Hamaguchi; Takao Kojima; Noriyuki Takeda; Chisato Nagata; Jun Takeda; Hiroshi Sarui; Yutaka Kawahito; Naohisa Yoshida; Atsushi Suetsugu; Takahiro Kato; Junichi Okuda; Kazunori Ida; Toshikazu Yoshikawa
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

10.  Body composition measured by dual-energy X-ray absorptiometry half-body scans in obese adults.

Authors:  Megan P Rothney; Robert J Brychta; Emily V Schaefer; Kong Y Chen; Monica C Skarulis
Journal:  Obesity (Silver Spring)       Date:  2009-02-19       Impact factor: 5.002

View more
  1 in total

Review 1.  Quantitative imaging techniques for the assessment of osteoporosis and sarcopenia.

Authors:  Sara Guerri; Daniele Mercatelli; Maria Pilar Aparisi Gómez; Alessandro Napoli; Giuseppe Battista; Giuseppe Guglielmi; Alberto Bazzocchi
Journal:  Quant Imaging Med Surg       Date:  2018-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.